H.Lee Moffitt Cancer Center & Research Institute

Sridevi Challa
Research Associate

Research Interests:

• AKT tyrosine 176 phosphorylation in tumor progression.



Selected Publications:

1. Mahajan K, Challa S, Coppola D, Lawrence H, Luo Y, Gevariya H, Zhu W, Chen YA, Lawrence NJ, Mahajan NP. Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity. Prostate. 2010 Mar 26;70(12):1274-1285. Pubmed ID: 20623637

2. Mahajan K, Coppola D, Challa S, Fang B, Chen YA, Zhu W, Lopez AS, Koomen J, Engelman RW, Rivera C, Muraoka-Cook RS, Cheng JQ, Sch?nbrunn E, Sebti SM, Earp HS, Mahajan N. Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation. PLoS One. 2010;5(3):e9646-.   Pubmed ID: 20333297







Sridevi Challa

Sridevi Challa
Research Associate

B.Tech Biotechnology, Indian Institute of Technology Madras

 

Contact:
SRB-4, Lab # 24234
Moffitt Cancer Center
12902 Magnolia Drive
Tampa, Florida 33612

Email:
Sridevi.Challa@moffitt.org